The Neuromuscular Disease Network for Canada

funder-logos_nmd4c

Early Career Member Profiles

Amanda Yaworski

Dr. Yaworski completed her undergraduate degree at Acadia University in Psychology and Neurosciences. Following this, she completed medical school at McMaster University and residency in Pediatric Neurology at the University of Alberta.

Read More

Élise Duchesne

As an independent researcher, Dr. Duchesne used her expertise to study muscle plasticity in highly prevalent neuromuscular diseases of the Saguenay–Lac-St-Jean region such as myotonic dystrophy type I (DM1). Her contributions to the field of neuromuscular diseases include the study of strength training effects on skeletal muscle impairments in DM1, the support of trial readiness by reaching international consensus on outcome measures and the documentation of metrological properties.

Read More

Gerald Pfeffer

Dr. Pfeffer is a clinician-scientist at University of Calgary. He did Neurology specialty training at UBC and Genetics PhD at Newcastle University. His clinical and research work focuses on adult-onset neurogenetic conditions.

Read More

Kiran Polavarapu

Dr. Kiran Polavarapu completed his PhD in 2019 at the National Institute of Mental Health and Neurosciences (NIMHANS) in India. He is an M.B.B.S (Bachelor of Medicine and Bachelor of Surgery) graduate who shifted his focus to research in neuromuscular disorders and neurogenetics. His research interest is in primary muscle disorders and neuromuscular genetics. He recently joined the Lochmüller Lab as a postdoctoral fellow and is looking forward to continuing research in neuromuscular genetics and Congenital Myathenic Syndrome.

Read More

Louise Moyle

Dr. Louise Moyle is a postdoctoral fellow at the Institute of Biomedical Engineering at the University of Toronto, Canada. Her research investigates mechanisms of muscle stem cell dysfunction in neuromuscular disorders, with the aim of transferring this knowledge towards future cell and gene therapies.

Read More

Martine Tetreault

Dr. Tetreault is an Assistant professor in the department of Neuroscience at Université de Montreal and a researcher at the CRCHUM since January 2018.  She completed her graduate studies in Molecular Biology at Université de Montreal under the supervision of Dr Bernard Brais (CIHR bursary). Her research was focusing on genetic characterization of neurological diseases in the French-Canadian population.

Read More

Melissa Bowerman

Dr. Bowerman is a Lecturer in Bioscience at the School of Medicine at Keele University, a group Member of the Wolfson Centre for Inherited Neuromuscular Disease in Oswestry and a principal investigator in the UK SMA Research Consortium.

Read More

Mireille Khacho

Dr. Khacho joined the Faculty of Medicine at the University of Ottawa as an Assistant Professor in the Department of Biochemistry, Microbiology and Immunology in January 2018. She is the Canada Research Chair tier2 in Mitochondrial Dynamics and Regenerative Medicine. She is also a member of the University of Ottawa Neuromuscular disease center and the Ottawa Institute of Systems Biology (OISB).

Read More

Mo Zhao

Dr. Mo Zhao completed her PhD in Molecular Genetics (2013-2017) in Dr. Robert Bryson-Richardson’s lab at Monash University (Melbourne, Australia) before joining Dr. James Dowling’s lab as a postdoctoral research fellow in the Department of Genetics & Genomic Biology at the Hospital for Sick Children in Toronto, Canada.

Read More

Natasha Chang

Dr. Natasha Chang is an Assistant Professor in the Department of Biochemistry at McGill University. She obtained her PhD with Dr. Gordon Shore at McGill University studying BCL-2 family proteins and their role in regulating the cell survival autophagy pathway.

Read More

Nicolas Dumont

Dr. Dumont became an assistant professor at the Université de Montréal in 2016, and he established his lab at the CHU Sainte-Justine research center. His research program is divided in 3 axes: 1) characterize the intrinsic mechanisms regulating muscle stem cell fate decision during myogenesis, 2) characterize the impact of rare genetic variants on muscle stem cell function, and 3) investigate novel therapeutic avenues targeting defective muscle stem cells to mitigate muscular dystrophies.

Read More